Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients.

Gómez-Jiménez J, Ribera E, Gasser I, Artaza MA, Del Valle O, Pahissa A, Martínez-Vázquez JM.

Antimicrob Agents Chemother. 1993 Aug;37(8):1587-92.

2.

Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.

Tuncer I, Topcu N, Durmus A, Turkdogan MK.

Hepatogastroenterology. 2003 Sep-Oct;50(53):1426-30.

PMID:
14571754
3.

Five days of ceftriaxone to treat culture negative neutrocytic ascites in cirrhotic patients.

Baskol M, Gursoy S, Baskol G, Ozbakir O, Guven K, Yucesoy M.

J Clin Gastroenterol. 2003 Nov-Dec;37(5):403-5.

PMID:
14564189
4.

Five days of ceftriaxone to treat spontaneous bacterial peritonitis in cirrhotic patients.

França A, Giordano HM, Sevá-Pereira T, Soares EC.

J Gastroenterol. 2002;37(2):119-22.

PMID:
11871762
5.

Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.

Sàbat M, Kolle L, Soriano G, Ortiz J, Pamplona J, Novella MT, Villanueva C, Sainz S, Torras J, Balanzó J, Guarner C.

Am J Gastroenterol. 1998 Dec;93(12):2457-62.

PMID:
9860409
6.

Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.

Fernández J, Ruiz del Arbol L, Gómez C, Durandez R, Serradilla R, Guarner C, Planas R, Arroyo V, Navasa M.

Gastroenterology. 2006 Oct;131(4):1049-56; quiz 1285.

PMID:
17030175
7.

Short-course ceftriaxone therapy in spontaneous bacterial peritonitis.

Javid G, Khan BA, Khan BA, Shah AH, Gulzar GM, Khan MA.

Postgrad Med J. 1998 Oct;74(876):592-5.

8.

Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients.

Ariza J, Xiol X, Esteve M, Fernández Bañeres F, Liñares J, Alonso T, Gudiol F.

Hepatology. 1991 Jul;14(1):91-8.

PMID:
2066075
9.

Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.

Novella M, Solà R, Soriano G, Andreu M, Gana J, Ortiz J, Coll S, Sàbat M, Vila MC, Guarner C, Vilardell F.

Hepatology. 1997 Mar;25(3):532-6.

PMID:
9049193
10.

Long-term prognosis of cirrhosis after spontaneous bacterial peritonitis treated with ceftriaxone.

França AV, De Souza JB, Silva CM, Soares EC.

J Clin Gastroenterol. 2001 Oct;33(4):295-8.

PMID:
11588542
11.

Enterococcus: not an innocent bystander in cirrhotic patients with spontaneous bacterial peritonitis.

Lee JH, Yoon JH, Kim BH, Chung GE, Myung SJ, Kim W, Kim YJ, Kim EC, Lee HS.

Eur J Clin Microbiol Infect Dis. 2009 Jan;28(1):21-6. doi: 10.1007/s10096-008-0578-3. Epub 2008 Jul 9.

PMID:
18612666
12.

Spontaneous ascitic infection in different cirrhotic groups: prevalence, risk factors and the efficacy of cefotaxime therapy.

Kaymakoglu S, Eraksoy H, Okten A, Demir K, Calangu S, Cakaloglu Y, Boztas G, Besisik F.

Eur J Gastroenterol Hepatol. 1997 Jan;9(1):71-6.

PMID:
9031903
13.

Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial.

Grangé JD, Roulot D, Pelletier G, Pariente EA, Denis J, Ink O, Blanc P, Richardet JP, Vinel JP, Delisle F, Fischer D, Flahault A, Amiot X.

J Hepatol. 1998 Sep;29(3):430-6.

PMID:
9764990
14.

Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease.

McCabe RE, Schlossberg D, Donowitz GR, Scheld WM, Zellner SR, Lindenberg LB, Armstrong JH, Ein ME.

Clin Ther. 1989 May-Jun;11(3):304-14.

PMID:
2663160
15.

Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis.

Cholongitas E, Papatheodoridis GV, Lahanas A, Xanthaki A, Kontou-Kastellanou C, Archimandritis AJ.

Liver Int. 2005 Feb;25(1):57-61.

PMID:
15698399
16.

Ceftriaxone in the treatment of spontaneous bacterial peritonitis: ascitic fluid polymorphonuclear count response and short-term prognosis.

Mesquita MA, Balbino EP, Albuquerque RS, Carmona CA, Okubo BT, Lorena SL, Montes CG, Soares EC.

Hepatogastroenterology. 1997 Sep-Oct;44(17):1276-80.

PMID:
9356840
17.

[A microbiological and clinical study of 57 cases of spontaneous bacterial peritonitis in liver cirrhosis patients].

Sáez-Royuela F, Gómez Rubio M, Fernández Guerrero ML, Díaz Curiel M, Hernández Guio C.

Rev Clin Esp. 1990 Nov;187(7):321-4. Spanish.

PMID:
2091110
18.

Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial.

Rolachon A, Cordier L, Bacq Y, Nousbaum JB, Franza A, Paris JC, Fratte S, Bohn B, Kitmacher P, Stahl JP, et al.

Hepatology. 1995 Oct;22(4 Pt 1):1171-4.

PMID:
7557868
19.

[Spontaneous bacterial peritonitis (SBP): prevalence and characteristics in a population of 314 cirrhotic patients evaluated at hospital admission].

Marelli A, Nardecchia L, De Gennaro F, Bodini P.

Minerva Med. 1999 Oct;90(10):369-75. Italian.

PMID:
10767910
20.

Selective intestinal decontamination prevents spontaneous bacterial peritonitis.

Soriano G, Guarner C, Teixidó M, Such J, Barrios J, Enríquez J, Vilardell F.

Gastroenterology. 1991 Feb;100(2):477-81.

PMID:
1985045
Items per page

Supplemental Content

Write to the Help Desk